Clinical Trial Update: Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for masitinib in combination with methotrexate in active rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED